GSK

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. GSK aims to positively impact the health of 2.5 billion people by the end of 2030. GSK's bold ambitions for patients is reflected in commitments to growth and a step-change in performance. GSK prioritises innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is an R&D focus on the science of the immune system, human genetics and advanced technologies, and world-leading capabilities in vaccines and medicines development. GSK focuses on four therapeutic areas: infectious diseases, HIV, immunology/respiratory and oncology